[1]
“Evaluating the Clinical Efficacy and Safety of Subcutaneous Rituximab in Non-Hodgkin Lymphoma: A Systematic Review”, TMJGM, vol. 1, no. 1, pp. 1–16, Oct. 2024, Accessed: Nov. 04, 2026. [Online]. Available: https://medicaljournalinternational.org/tmjgm/article/view/1